Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Names New CEO as Prepares to Accelerate Efforts

NEW YORK, May 17 – Nanogen announced Thursday that Vance Randy White had been appointed chief executive officer and would replace company founder Howard Birndorf, who will remain chairman of the company’s board.

The move appears to signal Nanogen’s efforts to accelerate its move into the clinical diagnostics arena.

"We welcome Randy and believe that his hands-on experience in clinical assay development and insight into the clinical markets will be an invaluable asset to Nanogen as it explores its opportunities to make its technology available to clinical diagnostics customers, such as hospitals and reference labs,” Birndorf said in a statement.

“We look forward to Randy's leadership and proven success to drive Nanogen's commercialization efforts of our products,” he said.

A representative of the San Diego-based company was not immediately available for comment.

White was most recently executive vice president of technical operations at American Medical Laboratories, a clinical reference laboratory.

Nanogen manufactures tthe NanoChip Cartridge and the NanoChip Molecular Biology Workstation.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.